Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.

Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.

Item
http://www.wikidata.org/entity/Q30245104
Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline DataEffects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysisCanagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.The effect of SGLT2 inhibitors on cardiovascular events and renal function.A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes.Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus.Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis.Comorbidities in Heart Failure.Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials.Canagliflozin and Cardiovascular disease- results of the CANVAS trialComparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis
P2860

Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.

Item
http://www.wikidata.org/entity/Q30245104
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
type
label
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
prefLabel
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
P2093
P304
P31
P356
10.1016/J.AMJCARD.2016.08.061
P407
P433
P478
P577
P698
P921